Cleared Traditional

K182681 - AC5 Topical Gel (FDA 510(k) Clearance)

Dec 2018
Decision
79d
Days
-
Risk

K182681 is an FDA 510(k) clearance for the AC5 Topical Gel. This device is classified as a Dressing, Wound, Drug.

Submitted by Arch Therapeutics, Inc. (Framingham, US). The FDA issued a Cleared decision on December 14, 2018, 79 days after receiving the submission on September 26, 2018.

This device falls under the General & Plastic Surgery FDA review panel.

Submission Details

510(k) Number K182681 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2018
Decision Date December 14, 2018
Days to Decision 79 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FRO - Dressing, Wound, Drug
Device Class -

Similar Devices - FRO Dressing, Wound, Drug

All 28
MiraChlor Antimicrobial Wound Solution
K252023 · Letus Corporation · Mar 2026
Promogran Prisma™ Collagen Matrix with ORC and Silver
K251999 · Solventum Germany GmbH · Mar 2026
LUOFUCON® Antimicrobial Wound Gel
K252028 · Huizhou Foryou Medical Co., Ltd. · Mar 2026
Redermax Antibacterial Wound Matrix
K251582 · Beijing Kreate Medical Co., Ltd. · Feb 2026
New Day Skin Spray
K252568 · Silk Holdings, Inc. · Jan 2026
SBC1 Cream
K250890 · Sioxmed, LLC · Jan 2026